title: Radiation dose and checkpoint blockade immunotherapy: unanswered questions.
authors.affiliation: Department of Radiation Oncology, Davis School of Medicine; University of California, Sacramento, CA, USA.
authors.forename: Arta M
authors.initials: AM
authors.lastname: Monjazeb
authors.affiliation: Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Center, Boston, MA, 02114, USA. Electronic address: jdschoenfeld@partners.org.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Schoenfeld
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D059248:Chemoradiotherapy / Q000379:methods*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000628:therapy*; D011836:Radiation Tolerance; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects* / Q000528:radiation effects*
chemical_list: D000911:Antibodies, Monoclonal; D011838:Radiation-Sensitizing Agents